Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-12

Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]

View source ↗

Summary

A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaques has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma | NA | Status: WITHDRAWN